SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Affymax, Inc. and Takeda Global Research & Development Center, Inc. Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011